Beijing Tong Ren Tang Chinese Medicine Gestion
Gestion contrôle des critères 0/4
Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.
Informations clés
Wang Chi
Directeur général
n/a
Rémunération totale
| Pourcentage du salaire du PDG | n/a |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | less than a year |
| Durée moyenne du mandat des membres du conseil d'administration | 2.3yrs |
Mises à jour récentes de la gestion
Recent updates
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up
Oct 04
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders
Sep 06Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?
Sep 02Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk
Feb 05Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Jan 03A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Sep 28Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today
Jul 12Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?
Mar 29Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28
Apr 28Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28
Mar 25Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?
Oct 27Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 28Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Mar 11What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Feb 04Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?
Jan 18
Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?
Dec 29Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Dec 11Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 23PDG
Wang Chi (49 yo)
less than a year
Titularisation
Mr. Wang Chi is Executive Director and Chief Executive Officer of Beijing Tong Ren Tang Chinese Medicine Company Limited from May 10, 2024. Mr. Chi has experience in Medical and Pharmaceutical industry. Mr...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | pas de données | pas de données | |
| Executive Director & Executive Deputy GM | less than a year | HK$975.00k | 0.0073% HK$ 479.0k | |
| CEO & Executive Director | less than a year | pas de données | pas de données | |
| CFO & Company Secretary | 4.5yrs | pas de données | pas de données | |
| Deputy GM & General Counsel | no data | pas de données | pas de données |
0.7yrs
Durée moyenne de l'emploi
50yo
Âge moyen
Gestion expérimentée: L'équipe de direction de 3613 n'est pas considérée comme expérimentée (ancienneté moyenne 0.7 ans), ce qui suggère une nouvelle équipe.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | pas de données | pas de données | |
| Executive Director & Executive Deputy GM | 4.7yrs | HK$975.00k | 0.0073% HK$ 479.0k | |
| CEO & Executive Director | less than a year | pas de données | pas de données | |
| Independent Non-Executive Director | 7.2yrs | HK$288.00k | pas de données | |
| Independent Non-Executive Director | 11.6yrs | HK$288.00k | pas de données | |
| Non-Executive Director | 2.3yrs | pas de données | pas de données | |
| Independent Non-Executive Director | 1.7yrs | HK$240.00k | pas de données |
2.3yrs
Durée moyenne de l'emploi
53yo
Âge moyen
Conseil d'administration expérimenté: Le conseil d'administration de la 3613 n'est pas considéré comme expérimenté ( 2.3 années d'ancienneté moyenne), ce qui suggère un nouveau conseil d'administration.